As of 2025-07-14, the EV/EBITDA ratio of Exagen Inc (XGN) is -13.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XGN's latest enterprise value is 162.13 mil USD. XGN's TTM EBITDA according to its financial statements is -12.29 mil USD. Dividing these 2 quantities gives us the above XGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 10.3x | 9.0x |
| Forward P/E multiples | 8.0x - 9.7x | 8.6x |
| Fair Price | (5.05) - (5.89) | (5.41) |
| Upside | -172.2% - -184.3% | -177.4% |
| Date | EV/EBITDA |
| 2025-07-11 | -13.19 |
| 2025-07-10 | -13.21 |
| 2025-07-09 | -12.91 |
| 2025-07-08 | -13.12 |
| 2025-07-07 | -13.14 |
| 2025-07-03 | -13.30 |
| 2025-07-02 | -13.15 |
| 2025-07-01 | -13.19 |
| 2025-06-30 | -13.17 |
| 2025-06-27 | -13.21 |
| 2025-06-26 | -13.19 |
| 2025-06-25 | -12.80 |
| 2025-06-24 | -13.31 |
| 2025-06-23 | -13.15 |
| 2025-06-20 | -13.62 |
| 2025-06-18 | -13.85 |
| 2025-06-17 | -14.50 |
| 2025-06-16 | -13.99 |
| 2025-06-13 | -13.42 |
| 2025-06-12 | -13.17 |
| 2025-06-11 | -13.67 |
| 2025-06-10 | -13.85 |
| 2025-06-09 | -13.51 |
| 2025-06-06 | -13.65 |
| 2025-06-05 | -13.54 |
| 2025-06-04 | -13.86 |
| 2025-06-03 | -13.90 |
| 2025-06-02 | -13.46 |
| 2025-05-30 | -13.12 |
| 2025-05-29 | -13.17 |
| 2025-05-28 | -12.68 |
| 2025-05-27 | -12.87 |
| 2025-05-23 | -12.50 |
| 2025-05-22 | -11.49 |
| 2025-05-21 | -11.03 |
| 2025-05-20 | -11.36 |
| 2025-05-19 | -12.02 |
| 2025-05-16 | -11.45 |
| 2025-05-15 | -10.97 |
| 2025-05-14 | -11.11 |
| 2025-05-13 | -10.78 |
| 2025-05-12 | -11.03 |
| 2025-05-09 | -10.92 |
| 2025-05-08 | -11.72 |
| 2025-05-07 | -12.91 |
| 2025-05-06 | -12.18 |
| 2025-05-05 | -11.88 |
| 2025-05-02 | -11.47 |
| 2025-05-01 | -11.68 |
| 2025-04-30 | -11.84 |